122 related articles for article (PubMed ID: 8622158)
1. Modulation effects of hexamethylene bisacetamide on growth and differentiation of cultured human malignant glioma cells.
Li XN; Du ZW; Huang Q
J Neurosurg; 1996 May; 84(5):831-8. PubMed ID: 8622158
[TBL] [Abstract][Full Text] [Related]
2. Growth-inhibitory and differentiation-inducing activity of dimethylformamide in cultured human malignant glioma cells.
Li XN; Du ZW; Huang Q; Wu JQ
Neurosurgery; 1997 Jun; 40(6):1250-8; discussion 1258-9. PubMed ID: 9179899
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and differentiation of C6 glioma cells on treatment with hmba.
Shirsat NV; Kayal JJ; Shaikh S; Mehta A
Cell Biol Int; 2001; 25(7):621-7. PubMed ID: 11448101
[TBL] [Abstract][Full Text] [Related]
4. [Differentiation effect of hexamethylene bisacetamide (HMBA) on mucoepidermoid carcinoma in vivo].
Jia B; Situ Z; Wu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Mar; 31(2):85-7. PubMed ID: 9387538
[TBL] [Abstract][Full Text] [Related]
5. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
6. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
7. [Effects of hexamethylene bisacetamide on P53 protein expression of MEC-1 cell line and cell differentiation].
Liu B; Situ Z; Wu J; Chen J
Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Feb; 17(1):17-9. PubMed ID: 12539312
[TBL] [Abstract][Full Text] [Related]
8. [Effects of hexamethylene bisacetamide on cell cycle and expression of its regulatory proteins in HL-60 cells].
Wang QH; Xie Y; Fan HH; Gao L; Liu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):480-4. PubMed ID: 14575541
[TBL] [Abstract][Full Text] [Related]
9. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells.
Guilbaud NF; Gas N; Dupont MA; Valette A
J Cell Physiol; 1990 Oct; 145(1):162-72. PubMed ID: 2211839
[TBL] [Abstract][Full Text] [Related]
10. [Differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA].
Ouyang GL; Li QF; Peng XX; Hong SG
Shi Yan Sheng Wu Xue Bao; 2001 Dec; 34(4):269-73. PubMed ID: 12549204
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanism underlying differentiation of HL-60 cells induced by hexamethylene bisacetamide].
Ren X; Wen PE; Yang WH; Tang TH; Ren HQ; Zhang ZY; Zhao HT; Fan H; Qiao GJ; Jiang GH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1030-4. PubMed ID: 18928589
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous responses of human colon carcinomas to hexamethylene bisacetamide.
Schroy PC; Carnright K; Winawer SJ; Friedman EA
Cancer Res; 1988 Oct; 48(19):5487-94. PubMed ID: 2458179
[TBL] [Abstract][Full Text] [Related]
14. Induction of phenotypic changes in SCLC cell lines in vitro by hexamethylene bisacetamide, sodium butyrate, and cyclic AMP.
Khan MZ; Freshney RI; McNicol AM; Murray AM
Ann Oncol; 1993 Jun; 4(6):499-507. PubMed ID: 8394737
[TBL] [Abstract][Full Text] [Related]
15. BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma.
Funck-Brentano E; Vizlin-Hodzic D; Nilsson JA; Nilsson LM
Epigenetics; 2021 Jan; 16(1):54-63. PubMed ID: 32603264
[TBL] [Abstract][Full Text] [Related]
16. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
Snyder SW; Egorin MJ; Geelhaar LA; Hamburger AW; Callery PS
Cancer Res; 1988 Jul; 48(13):3613-6. PubMed ID: 3163938
[TBL] [Abstract][Full Text] [Related]
17. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
Richon VM; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
[TBL] [Abstract][Full Text] [Related]
18. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
19. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide.
Naito S; Obayashi S; Sumi T; Iwai S; Nakazawa M; Ikuta K; Yura Y
Cancer Gene Ther; 2006 Aug; 13(8):780-91. PubMed ID: 16645620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
